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Health Services Research
Opportunities for Pathology
Fred SanﬁlippoFrom the Department of Pathology and Laboratory Medicine, School of Medicine, and the Department of Health Policy and Management, Rollins School of
Public Health, Emory University, Atlanta, GeorgiaHealth services research (HSR) is a rapidly growing area of
research and training, with signiﬁcant applications to pa-
tients, providers, and society, that offers tremendous op-
portunities for pathologists to affect the health of our
community. The limited involvement of anatomical and
clinical pathologists in HSR largely reﬂects the historical
focus of pathology research on the mechanisms and mani-
festations of disease. However, HSR provides extraordinary
potential for pathologists to study the direct impact of their
clinical research and diagnostic services on health care
outcomes, access, and cost.Accepted for publication June 30, 2014.
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What actually is HSR? Although HSR has a variety of
deﬁnitions, they all focus on the study of health care quality
(eg, outcomes, safety, and satisfaction), access, and cost.
Academy Health, the largest professional HSR society,
provided a detailed deﬁnition and description of HSR in
2000 (http://www.academyhealth.org/About/content.cfm?
ItemNumberZ831&navItemNumberZ514, last accessed
July 22, 2014) with the simple summary that HSR is the
scientiﬁc study of health care delivery asking what works,
for whom, at what cost, and under what circumstances. The
Agency for Healthcare Research and Quality deﬁned the
goals of HSR in 2002 as ﬁnding “the most effective ways to
organize, manage, ﬁnance, and deliver high-quality care;
reduce medical errors; and improve patient safety” (http://
archive.ahrq.gov/about/whatis.htm, last accessed July 22,
2014).
Several types of research signiﬁcantly overlap or are
components of HSR. These include comparative effective-
ness research, which studies the impact of an intervention at a
population level; implementation-dissemination science,
which studies how evidence-based practices are adopted byCopyright ª 2014 American Society for Investigative Pathology.
Published by Elsevier Inc. All rights reserved.
http://dx.doi.org/10.1016/j.ajpath.2014.06.007appropriate populations; and delivery system research, which
studies the effectiveness and efﬁciency of health care pro-
viders. A major characteristic of HSR is its multidisciplinary
nature. Whether at the level of prevention, diagnosis, or
treatment, HSR usually involves one or more health science
disciplines. Because HSR often includes other factors, such
as social determinants, environment, personal behaviors,
economics, regulations/policy, work processes, human re-
sources, or technology, it may also involve disciplines in the
social sciences, humanities, business, law, and engineering.
With the increasing emphasis on translational research by
the NIH (Bethesda,MD) and others, a shorthand nomenclature
has been developed by a variety of organizations and authors,
unfortunately yielding inconsistent deﬁnitions, especially as
related to HSR. Some deﬁne two categories of translational
research: T1 (basic to clinical) and T2 (clinical to population)
(NIHeBehavioral and Social Sciences Research, http://obssr.
od.nih.gov/scientiﬁc_areas/translation/index.aspx, last ac-
cessed July 22, 2014). Others use T1, T2, and T3 to represent
transitions between basic-patient, patient-population, and
basic-population research,1 whereas others use ﬁve categories,
including T0 (basic biomedical research), T1 (clinical trans-
lation), T2 (demonstrating efﬁcacy), T3 (translation to prac-
tice), and T4 (translation to populations)2 (Institute of
Translational Health Sciences, https://www.iths.org/about/
translational, last accessed July 22, 2014). Thus, HSR may
represent T2 in the ﬁrst scheme, T2 and T3 in the second
scheme, or T3 and T4 in the third scheme, which is becoming
most widely accepted.
Table 1 HSR Opportunities in Pathology
Diagnostic services:
anatomical and clinical
pathology
Comparative effectiveness, safety
Use, access, cost
Delivery models, method
Technology: analytic,
information,
communications
Analytic performance
Use, access, cost
Population data repositories
Decision support:
providers, payers,
patients
Test selection
Interpretation
Clinical application
Health Services Research for PathologyThe importance of HSR has increased dramatically during
the past few years, largely as a result of public attention and
demands to address the well-recognized, complex, and
interdependent problems of US health care cost, quality, and
access.3,4 The socioeconomic-political debates about health
care delivery in the United States have, if nothing else, made
it clear that effective solutions must be based more on ev-
idence than rhetoric. Adding to the urgency of HSR studies
is the rapid transition underway toward delivery models
based on population health, which are signiﬁcantly affected
by many confounding factors, of which the impact on spe-
ciﬁc cohorts in various settings is poorly understood. These
include the multidisciplinary parameters mentioned above,
as well as the nature of health plans and provider systems.
Rigorous population-based HSR studies provide many
challenges, including the need to develop larger and more
complex big data repositories that include the necessary
social and biomedical covariates, as well as appropriate and
sometimes novel biostatistical and informatics approaches
for analysis of the questions under study.5
As the ﬁeld of HSR has expanded in scope, scale, and public
importance, the attention and support fromgovernment agencies
and other organizations have also increased. TheNIH generated
the HSR Information Central in 2005 to provide information on
HSR topics of activity and funding opportunities across all
government agencies, which recently has been combined with
information on public health (http://www.nlm.nih.gov/hsrph.
html, last accessed July 22, 2014). This site also provides Gen-
eral Resources information on HSR data, tools, meetings,
legislation, organizations, and publications. More recently, the
generation of the National Center for Advancing Translational
Sciences, by NIH, to advance translational science has HSR as
one of its pillars. The US Department of Veterans Affairs now
has >20 Health Services Research and Development Centers
across the country. In addition, as part of the Patient Protection
and Affordable Care Act, the Centers for Medicare and
Medicaid Services Center for Medicare and Medicaid Innova-
tion and the independent Patient-Centered Outcomes
Research Institute were generated to support HSR with new
and signiﬁcant funding streams (Centers for Medicare and
MedicaidServices,http://innovation.cms.gov/initiatives/Health-
Care-Innovation-Awards/Round-2.html; Patient-Centered
Outcomes Research Institute, http://www.pcori.org/funding-
opportunities/funding-center, last accessed July 22, 2014).
There also is increasing federal support to train scientists in
HSR; for example, 18 institutions have T32 grants supporting
predoctoral and post-doctoral HSR Training Programs, 60 in-
stitutionswithClinical andTranslational ScienceAward grants
have clinical research training programs, and the US Depart-
ment of Veterans Affairs Health Services Research and
Development supports 15HSR Fellowship programs. Funding
and/or support of HSR and training is also the major emphasis
of numerous private foundations, professional societies, and
research and patient advocacy organizations.
With this growth of interest, organizations, and funding
has come a concomitant growth in publications with a focusThe American Journal of Pathology - ajp.amjpathol.orgon HSR. Most general medical journals, such as the The
New England Journal of Medicine and The Journal of the
American Medical Association, as well as clinically oriented
medical specialty journals, including those in pathology,
have a long history of publishing HSR studies. However, an
increasing number of professional journals are becoming
devoted to HSR and its subspecialties, including Health
Affairs, Health Services Research, Health Services Man-
agement Research, Health Services Research and Policy,
Implementation Science, Medical Care, and Medical Care
Research and Review.Opportunities for Pathology
Research in pathology is largely focused on the biomedical
mechanisms and in vitro manifestations of disease, and
although some pathology subspecialties, such as transfusion
medicine and cytopathology, provide direct interactions with
patients, most pathology diagnostic services do not. Never-
theless, the interest of pathologists in population health and
HSR goes back to the impact both Rudolf Virchow and
William Welch had in developing public health systems in
their respective countries. As the father of modern pathology,
Virchowwas also a scientiﬁc and political force in developing
public health projects throughout Germany and was noted as
one of the founders of social medicine.6 After establishing the
pathology department and medical school at Johns Hopkins
University, Welch generated and served as initial dean of
the ﬁrst school of public health in the United States, which
has become widely recognized for its HSR (http://www.
nasonline.org/publications/biographical-memoirs/memoir-
pdfs/welch-william.pdf, last accessed July 22, 2014).
More recently, pathologists have extended their basic and
diagnostic research activities in pathology to clinical and
population health settings. A striking example is the work of
J. Brooks Jackson and colleagues (reviewed by Anderson7),
who translated their molecular pathology studies in HIV to
develop diagnostics, therapeutics, and rigorous HSR studies
in Uganda, China, and the United States that established
population-based, cost-effective methods of preventing
neonatal HIV transmission and that have saved thousands of
lives.
Many HSR opportunities exist within the scope of diag-
nostic anatomical and clinical pathology, especially related2367
Sanﬁlippoto the delivery of services and use of technology (Table 1).
The most evident area for HSR studies in pathology center
around the outcome, safety, efﬁcacy, access, and cost of
diagnostic services. Comparative effectiveness research
examining sensitivity, speciﬁcity, predictive value, and cost
effectiveness is a core HSR question, especially when
applied to population health. The appropriate use of tests for
screening versus diagnosis in speciﬁc patient cohorts has
become more controversial in the public dialogue on health
care delivery. Whether the discussion is about the use of
prostate-speciﬁc antigen testing and prostate biopsy speci-
mens or molecular genetic testing and breast biopsy speci-
mens, pathologists can and should be key ﬁgures in the
design and implementation of studies that provide evidence-
based answers to questions of the safety, efﬁcacy, and cost
of diagnostic tests. In addition to the clinical parameters
involved in assessing diagnostic effectiveness and efﬁciency
are the analytic parameters tied to the technology used,
providing another area for HSR studies that can be led by
pathologists.
The information accumulated by pathology services also
provides extensive opportunities for HSR, especially in
developing effective methods to recognize population health
trends. The pathologist has access to a wealth of diagnostic
data from the patient community that could rapidly identify
an impending infectious epidemic or toxic environmental
issue, as well as to track the development of more insidious
population health problems, manifested by data from the
laboratory, surgical pathology, or the autopsy service.
Translating these data to information that leads to effective
interventions is an area of HSR that is of high priority to
public health services at the local, state, and federal levels.
Perhaps the greatest area of HSR impact for pathology is
in the development of diagnostic decision support algo-
rithms and tools for providers, payers, and patients. Studies
to deﬁne appropriate diagnostic test order sets for speciﬁc
patient populations has substantial impact on outcomes and
cost, as does the determination of appropriate follow-up
tests and the need for second opinions on tests involving
interpretation. Likewise, HSR to identify the most effective
means of determining, transmitting, and implementing test
results for speciﬁc patients is increasing in importance as the
number and complexity of diagnostic tools expand.
An emerging area of decision support HSR in pathology
is in direct patient interactions. With regulatory changes
providing greater ease of direct access by patients to their
own test results, the importance of providing timely and
accurate interpretation and advice directly to patients is2368likely to increase dramatically. HSR studies will be impor-
tant to identify the most effective approaches for translating
test results to useful knowledge and appropriate action by
patients seeking help. Likewise, HSR studies on the analytic
aspects of direct-to-patient diagnostic testing, especially
regarding informatics and technology, will have a major
bearing on access and cost as well as outcomes.
As detailed above, there are a wide range of potential
funding sources for pathology-related HSR, as well as many
venues for publication of results. For many pathology de-
partments without the experience or infrastructure to support
HSR, the NIH website (http://www.nlm.nih.gov/hsrph.html,
last accessed July 22, 2014) can be a valuable resource,
along with An Organizational Guide to Building Health
Services Research Capacity, published by the Agency for
Healthcare Research and Quality.8
In summary, there are extensive opportunities for HSR
across the sub-specialties of pathology and laboratory
medicine that can quickly and signiﬁcantly affect the out-
comes, access, and cost of health care. Driving these
increased opportunities has been increased public awareness
and demand for improved health care services, making it
incumbent on pathology as a discipline and pathologists in
research to focus greater effort in HSR and the training of
future HSR investigators.References
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